Bacterial Infections

New guidelines from the Society of Healthcare Epidemiology of America address protocols for preventing the spread of infections including Clostridium difficile, MRSA, and more.

Accurately distinguishing bacterial infections from viral ones can be difficult, often leading to antibiotic misuse. In a new study, researchers tested the accuracy of a novel assay in distinguishing...

Delafloxacin is non-inferior to vancomycin plus aztreonam for treating acute bacterial skin and skin-structure infections

The lipoglycopeptide dalbavancin, known for its efficacy against pathogens that cause acute bacterial skin and skin structure infections (ABSSSI), has been approved by the FDA as a single- or 2-dose...

The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.

The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.

The US Food and Drug Administration has approved 3 formulations of a commonly prescribed antibiotic in injection form.

Newer diagnostic tests should be used to evaluate patients at risk for active or latent tuberculosis (TB) infection, according to updated guidelines.

The US Preventive Services Task Force has updated its 1996 guidelines on the screening of individuals for asymptomatic tuberculosis.

A recent study explored the safety, efficacy, and required treatment duration of interferon-free treatment of acute hepatitis C virus infection.